United States · FDA National Drug Code directory
Triple Antibiotic
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82942-1002_369d6dd7-ae55-e456-e063-6294a90ab143
- Product NDC
- 82942-1002
- Form
- CREAM
- Composition / generic term
- BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, POLYMYXIN B
- Labeler
- J&A Digital Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20221001
- Source listing expiry
- 20261231
Source-listed ingredients
- BACITRACIN ZINC — 400 [CFU]/g
- NEOMYCIN SULFATE — 3.5 mg/g
- POLYMYXIN B SULFATE — 5000 [CFU]/g
These values do not establish equivalence or a dose recommendation.
Packages
- .9 g in 1 PACKET (82942-1002-1) · 82942-1002-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →